Loading Events

Eupraxia Pharmaceuticals Virtual Event: Catalyst Preview – An Overview of the Upcoming Interim Data for EP-104GI for Eosinophilic Esophagitis (EoE)

Eupraxia-Banner-1-1
DATE: November 13, 2026
TIME: 8:30 AM EST
LOCATION: Virtual

About The Event

Join Eupraxia Pharmaceuticals for a virtual webcast with company management to discuss an important upcoming catalyst.

In December, interim data from the placebo-controlled portion of the RESOLVE trial will be released. During the webinar, management will review clinical data from EP-104GI in EoE from Part 1 of the trial and provide details of what to expect in the interim data for Part 2.